206
Views
3
CrossRef citations to date
0
Altmetric
Systematic Review

A review of risk factors for retinal vein occlusions

, , ORCID Icon, , , ORCID Icon & show all
Pages 761-772 | Received 12 May 2022, Accepted 09 Aug 2022, Published online: 19 Aug 2022

References

  • Cheung N, Klein R, Wang JJ, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Investig Ophthalmol Vis Sci. 2008;49(10):4297–4302.
  • Woo SCY, Lip GYH, Lip PL. Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review. Eye (Lond). 2016;30(8):1031–1038.
  • Park SJ, Choi N-K, Park KH, et al. Nationwide incidence of clinically diagnosed retinal vein occlusion in Korea, 2008 through 2011: preponderance of women and the impact of aging. Ophthalmology. 2014;121(6):1274–1280.
  • Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. the blue mountains eye study. Arch Ophthalmol (Chicago, Ill 1960). 1996;114(10):1243–1247.
  • Haymore JG, Mejico LJ. Retinal vascular occlusion syndromes. Int Ophthalmol Clin. 2009;49(3):63–79.
  • MacDonald D. The ABCs of RVO: a review of retinal venous occlusion. Clin Exp Optom. 2014;97(4):311–323.
  • Zhao J, Sastry SM, Sperduto RD, et al. Arteriovenous crossing patterns in branch retinal vein occlusion. the eye disease case-control study group. Ophthalmology. 1993;100(3):423–428.
  • Jefferies P, Clemett R, Day T, et al. An anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusions. Aust N Z J Ophthalmol. 1993;21(4):213–217.
  • Christoffersen NL, Larsen M, C NLB, et al. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology. 1999;106(11):2054–2062.
  • Duker JS, Brown GC, D JS, et al. Anterior location of the crossing artery in branch retinal vein obstruction. Arch Ophthalmol. 1989;107(7):998–1000.
  • Green WR, Chan CC, Hutchins GM, et al. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371–422.
  • Janssen MCH, den Heijer M, Cruysberg JRM, et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005;93(6):1021–1026.
  • Yau JWY, Lee P, Wong TY, et al. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J. 2008;38(12):904–910.
  • Kumagai K, Tsujikawa A, Muraoka Y, et al. Three-dimensional optical coherence tomography evaluation of vascular changes at arteriovenous crossings. Invest Ophthalmol Vis Sci. 2014;55(3):1867–1875.
  • Guidoboni G, Harris A, Cassani S, et al. Intraocular pressure, blood pressure, and retinal blood flow autoregulation: a mathematical model to clarify their relationship and clinical relevance. Invest Ophthalmol Vis Sci. 2014;55(7):4105–4118.
  • Kiel JW. The Ocular Circulation. Ocul Circ. Vol. Chapter 4. San Rafael, California (USA): University of Texas Health Science Center at San Antonio: Morgan & Claypool Life Sciences; 2010.
  • Kida T. Mystery of retinal vein occlusion: vasoactivity of the vein and possible involvement of endothelin-1. Biomed Res Int. 2017;2017:4816527.
  • Jacks AS, Miller NR. Spontaneous retinal venous pulsation: aetiology and significance. J Neurol Neurosurg Psychiatry. 2003;74(1):7–9.
  • Zapuskalova J, Sindeeva JN, V ZI, et al. The mechanism of retinal vessel pulsation on the optic nerve head. Invest Ophthalmol Vis Sci. 2004;45(1):36.
  • Arej N, Vasseur V, Jabbour E, et al. Assessment of spontaneous retinal arterial pulsations in acute central retinal vein occlusions. Cerviño A, editor J ophthalmol. 2020;2020:3107472.
  • Morgan WH, Hazelton ML, Yu D-Y. Retinal venous pulsation: expanding our understanding and use of this enigmatic phenomenon. Prog Retin Eye Res. 2016;55:82–107.
  • Fraenkl SA, Mozaffarieh M, Flammer J. Retinal vein occlusions: the potential impact of a dysregulation of the retinal veins. EPMA J. 2010;1(2):253–261.
  • Symons MJ, Moore DT. Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol. 2002;55(9):893–899.
  • Ranganathan P, Aggarwal R, Pramesh CS. Common pitfalls in statistical analysis: odds versus risk. Perspect Clin Res. 2015;6(4):222–224.
  • Stare J, M-B D. Odds ratio Hazard ratio and relative risk. Metod Zv. 2016;13:59–67.
  • Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(16). DOI: 10.1186/1745-6215-8-16
  • Goldacre MJ, Wotton CJ, Keenan TDL. Risk of selected eye diseases in people admitted to hospital for hypertension or diabetes mellitus: record linkage studies. Br J Ophthalmol. 2012;96(6):872–876.
  • Chang Y-S, Weng S-F, Chang C, et al. Risk of retinal vein occlusion following end-stage renal disease. Medicine (Baltimore). 2016;95(16):e3474.
  • Hashimoto Y, Kaneko H, Okada A, et al. Association between retinal vein occlusion and Life’s Simple 7 cardiovascular health metrics: a large claims database study. Ophthalmol Retin. 2022;6(8):684–692.
  • Newman-Casey PA, Stem M, Talwar N, et al. Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan. Ophthalmology. 2014;121(10):1939–1948.
  • Stem MS, Talwar N, Comer GM, et al. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology. 2013;120(2):362–370.
  • Bertelsen M, Linneberg A, Christoffersen N, et al. Mortality in patients with central retinal vein occlusion. Ophthalmology. 2014;121(3):637–642.
  • Kim J, Lim DH, Han K, et al. Retinal vein occlusion is associated with low blood high-density lipoprotein cholesterol: a nationwide cohort study. Am J Ophthalmol. 2019;205:35–42.
  • CJCHC-H S, S-MMSSY O, CJCHC-H S, et al. Bidirectional association between the risk of comorbidities and the diagnosis of retinal vein occlusion in an elderly population: a nationwide population-based study. Int J Cardiol. 2015;178:256–261.
  • Paik DW, Han K, Kang SW, et al. Differential effect of obesity on the incidence of retinal vein occlusion with and without diabetes: a Korean nationwide cohort study. Sci Rep. 2020;10(1):10512.
  • Zhang H-W, Lin C-W, Kok VC, et al. Incidence of retinal vein occlusion with long-term exposure to ambient air pollution. PLoS One. 2019;14(9):e0222895.
  • Chang Y-S, C-H H, Chu C-C, et al. Risk of retinal vein occlusion in patients with diabetes mellitus: a retrospective cohort study. Diabetes Res Clin Pract. 2021;171:108607.
  • Lee J, Choe HR, Park SH, et al. Impact of kidney transplantation on the risk of retinal vein occlusion in end-stage renal disease. Sci Rep. 2021;11(1):11583.
  • Moon TH, Han JH, Kang M, et al. The nationwide incidence of retinal vein occlusion following dialysis due to end-stage renal disease in Korea, 2004 through 2013. J Korean Med Sci. 2021;36(30):e201.
  • Ha M, Han K, Jung Y, et al. Is retinal vein occlusion associated with depression symptoms?: A nationwide cohort study. Medicine (Baltimore). 2021;100(32):e26937.
  • Bertelsen M, Linneberg A, Rosenberg T, et al. Comorbidity in patients with branch retinal vein occlusion: case-control study. BMJ. 2012;345(nov30 1):e7885.
  • Bucciarelli P, Passamonti SM, Gianniello F, et al. Thrombophilic and cardiovascular risk factors for retinal vein occlusion. Eur J Intern Med. 2017;44:44–48.
  • Risk factors for central retinal vein occlusion. The eye disease case-control study group. Arch Ophthalmol (Chicago, Ill 1960). 1996;114:545–554.
  • Weger M, Renner W, Steinbrugger I, et al. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. Ophthalmology. 2005;112(11):1910–1915.
  • Koizumi H, Ferrara DC, Brue C, et al. Central retinal vein occlusion case-control study. Am J Ophthalmol. 2007;144(6):858–863.e1.
  • Sahin A, Sahin M, Yüksel H, et al. The mean platelet volume in patients with retinal vein occlusion. J Ophthalmol. 2013;2013:236371.
  • Schwaber EJ, Fogelman N, Sobol EK, et al. Associations with retinal vascular occlusions in a diverse, urban population. Ophthalmic Epidemiol. 2018;25(3):220–226.
  • Sofi F, Mannini L, Marcucci R, et al. Role of haemorheological factors in patients with retinal vein occlusion. Thromb Haemost. 2007;98(12):1215–1219.
  • Sofi F, Marcucci R, Fedi S, et al. High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion. Atherosclerosis. 2010;210(1):278–281.
  • Sottilotta G, Siboni SM, Latella C, et al. Hyperhomocysteinemia and C677T MTHFR genotype in patients with retinal vein thrombosis. Clin Appl Thromb. 2010;16(5):549–553.
  • Thapa R, Paudyal G, Bernstein PS. Demographic characteristics, patterns and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control study. Clin Exp Ophthalmol. 2010;38(6):583–590.
  • Risk factors for branch retinal vein occlusion. The eye disease case-control study group. Am J Ophthalmol. 1993;116(3):286–296.
  • Shin YU, Cho H, Min KJ, et al. Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012 A cross-sectional observational study. Med (United States). 2016;95:e5185.
  • Yoo HJ, Choi KM. Adipokines as a novel link between obesity and atherosclerosis. World J Diabetes. 2014;5(3):357–363.
  • Siasos G, Tsigkou V, Kokkou E, et al. Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr Med Chem. 2014;21(34):3936–3948.
  • Meier MH, Gillespie NA, Hansell NK, et al. Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults. Psychosom Med. 2014;76(9):732–738.
  • Sun C, Tikellis G, Klein R, et al. Are microvascular abnormalities in the retina associated with depression symptoms? The cardiovascular health study. Am J Geriatr Psychiatry off J Am Assoc Geriatr Psychiatry. 2007;15(4):335–343.
  • Pratt LA, Ford DE, Crum RM, et al. Depression, psychotropic medication, and risk of myocardial infarction. prospective data from the Baltimore ECA follow-up. Circulation. 1996;94(12):3123–3129.
  • Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998;155(1):4–11.
  • Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911.
  • S-Y W, Nemesure B, Hennis A, et al. Nine-year changes in intraocular pressure: the Barbados Eye Studies. Arch Ophthalmol (Chicago, Ill 1960). 2006;124(11):1631–1636.
  • Yip JLY, Aung T, Wong T-Y, et al. Socioeconomic status, systolic blood pressure and intraocular pressure: the Tanjong Pagar Study. Br J Ophthalmol. 2007;91(1):56–61.
  • Klein BEK, Klein R, Knudtson MD. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol. 2005;89(3):284–287.
  • Dielemans I, Vingerling JR, Algra D, et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. the Rotterdam Study. Ophthalmology. 1995;102(1):54–60.
  • Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.
  • Valencia-Rodríguez A, Vera-Barajas A, Barranco-Fragoso B, et al. New insights into the association between non-alcoholic fatty liver disease and atherosclerosis. Ann Transl Med. Dec 2019;7(Suppl S8):S300–S300.
  • Xu X, Lu L, Dong Q, et al. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids Health Dis. 2015;14(1):158.
  • Gaudio E, Nobili V, Franchitto A, et al. Nonalcoholic fatty liver disease and atherosclerosis. Intern Emerg Med. 2012;7(S3):297–305.
  • Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2011;63(3):213–217.
  • Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003;23(12):2131–2137.
  • Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005;24(4):493–519.
  • Hayreh SS, Zimmerman B, McCarthy MJ, et al. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131(1):61–77.
  • Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmol J Int D’ophtalmologie Int J Ophthalmol Zeitschrift fur Augenheilkd. Switzerland. 2019:242(3):123–162. 162. DOI:10.1159/000502041
  • The royal college of ophthalmologists. Clinical Guidelines Retinal Vein Occlusion (RVO). 2022.
  • Cornel S, Adriana ID, Mihaela TC, et al. Anti-vascular endothelial growth factor indications in ocular disease. Rom J Ophthalmol. 2015;59(4):235–242.
  • Ageno W, Beyer-Westendorf J, Garcia DA, et al. Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis. 2016;41(1):129–143.
  • Katsi V, Marketou M, Vlachopoulos C, et al. Impact of arterial hypertension on the eye. Curr Hypertens Rep. 2012;14(6):581–590.
  • Talcott K. RVO: diagnosis and Management A comprehensive look at occlusions’ etiology, risk factors, signs, symptoms and treatment. Rev Ophthalmol. 2021.
  • V VHT, Keeffe JE, McCarty CA, et al. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol. 2005;89(3):360–363.
  • Köberlein J, Beifus K, Schaffert C, et al. The economic burden of visual impairment and blindness: a systematic review. BMJ Open. 2013;3(11):e003471.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.